Fox Chase Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center research facility and hospital located in the Fox Chase section of Philadelphia, Pennsylvania, United States. The main facilities of the center are located on property adjoining Burholme Park.

During the past decade, Fox Chase Cancer Center 333 Cottman Avenue conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fox Chase Cancer Center 333 Cottman Avenue" #1 collaborator was "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fox Chase Cancer Center 333 Cottman Avenue" are "Melanoma Stage IIIB/C" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Fox Chase Cancer Center 333 Cottman Avenue" in a lesser frequency.

Most popular intervention types in "Fox Chase Cancer Center 333 Cottman Avenue" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adjuvant therapy" (1 trials), "Daromun" (1 trials), "Paclitaxel+Reparixin" (1 trials) and "Surgery" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fox Chase Cancer Center 333 Cottman Avenue" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Fox Chase Cancer Center 333 Cottman Avenue". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fox Chase Cancer Center 333 Cottman Avenue, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fox Chase Cancer Center 333 Cottman Avenue, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".